Henan Taloph Pharmaceutical Stock Co Ltd (600222) — Capital Reinvestment Ratio
Henan Taloph Pharmaceutical Stock Co Ltd (600222) has a Capital Reinvestment Ratio of 0.24x as of September 2025, meaning it reinvests 0% of its operating cash flow (CN¥22.69 Million) in capital expenditures (CN¥5.45 Million). Check Henan Taloph Pharmaceutical Stock Co Ltd tangible equity quality to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Henan Taloph Pharmaceutical Stock Co Ltd Capital Reinvestment Ratio (1998–2025)
This chart tracks Henan Taloph Pharmaceutical Stock Co Ltd's Capital Reinvestment Ratio across 24 annual periods. For the full cash flow conversion analysis, see Henan Taloph Pharmaceutical Stock Co Ltd (600222) cash flow conversion.
Annual Capital Reinvestment Ratio for Henan Taloph Pharmaceutical Stock Co Ltd (1998–2025)
Year-by-year Capital Reinvestment Ratio for Henan Taloph Pharmaceutical Stock Co Ltd from 1998 to 2025. See cash generation quality of Henan Taloph Pharmaceutical Stock Co Ltd to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.45x | CN¥47.16 Million | CN¥21.12 Million | ▼ -54.6% |
| 2023 | 0.99x | CN¥43.74 Million | CN¥43.13 Million | ▲ +151.5% |
| 2021 | 0.39x | CN¥99.66 Million | CN¥39.07 Million | ▼ -60.4% |
| 2020 | 0.99x | CN¥73.43 Million | CN¥72.65 Million | ▼ -61.8% |
| 2019 | 2.59x | CN¥41.53 Million | CN¥107.68 Million | ▲ +366.5% |
| 2018 | 0.56x | CN¥119.47 Million | CN¥66.41 Million | ▼ -71.0% |
| 2017 | 1.91x | CN¥23.17 Million | CN¥44.34 Million | ▲ +126.7% |
| 2016 | 0.84x | CN¥70.60 Million | CN¥59.60 Million | ▼ -33.0% |
| 2015 | 1.26x | CN¥49.27 Million | CN¥62.04 Million | ▲ +216.5% |
| 2014 | 0.40x | CN¥89.54 Million | CN¥35.62 Million | ▲ +133.4% |
| 2012 | 0.17x | CN¥87.45 Million | CN¥14.91 Million | ▼ -100.0% |
| 2011 | 612.28x | CN¥105.20K | CN¥64.41 Million | ▲ +46377.1% |
| 2009 | 1.32x | CN¥21.45 Million | CN¥28.25 Million | ▼ -41.7% |
| 2008 | 2.26x | CN¥18.13 Million | CN¥40.98 Million | ▲ +13.7% |
| 2007 | 1.99x | CN¥21.34 Million | CN¥42.42 Million | ▼ -91.4% |
| 2006 | 22.99x | CN¥1.59 Million | CN¥36.64 Million | ▼ -69.0% |
| 2005 | 74.04x | CN¥276.30K | CN¥20.46 Million | ▲ +8971.7% |
| 2004 | 0.82x | CN¥18.25 Million | CN¥14.90 Million | ▼ -81.9% |
| 2003 | 4.52x | CN¥3.74 Million | CN¥16.89 Million | ▲ +430.5% |
| 2002 | 0.85x | CN¥7.47 Million | CN¥6.36 Million | ▼ -20.2% |
| 2001 | 1.07x | CN¥55.03 Million | CN¥58.73 Million | ▼ -99.1% |
| 2000 | 123.50x | CN¥875.36K | CN¥108.11 Million | ▲ +15260.6% |
| 1999 | 0.80x | CN¥99.32 Million | CN¥79.86 Million | ▲ +63076.1% |
| 1998 | 0.00x | CN¥28.04 Million | CN¥35.69K | — |